Dow Jones

40 003,59

0,34%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Pain Therapeutics, Inc. (MM) (PTIE)
Pain Therapeutics, Inc. (MM) (PTIE) Actualités

PTIE

Pain Therapeutics (PTIE)

Pain Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:PTIE

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
29/03/2019	13h25	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
29/03/2019	11h09	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
27/03/2019	20h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
27/03/2019	13h30	GlobeNewswire Inc.	Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
25/03/2019	13h30	GlobeNewswire Inc.	Pain Therapeutics Reports 2018 Financial Results and Corporate Update	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
04/03/2019	20h56	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
14/02/2019	21h04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
05/02/2019	14h00	GlobeNewswire Inc.	Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
31/01/2019	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
17/01/2019	15h00	GlobeNewswire Inc.	Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
16/01/2019	15h00	GlobeNewswire Inc.	Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
07/01/2019	14h30	GlobeNewswire Inc.	Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
19/12/2018	00h00	GlobeNewswire Inc.	Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
18/12/2018	23h29	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
06/12/2018	13h30	GlobeNewswire Inc.	Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
12/11/2018	13h30	GlobeNewswire Inc.	Pain Therapeutics Appeals FDA Decision on REMOXY	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
01/11/2018	21h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
31/10/2018	21h04	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
30/10/2018	21h44	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
29/10/2018	21h05	GlobeNewswire Inc.	Pain Therapeutics Reports Third Quarter 2018 Financial Results	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
23/10/2018	13h30	GlobeNewswire Inc.	Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
11/10/2018	13h30	GlobeNewswire Inc.	Pain Therapeutics Announces Appointment of Chief Financial Officer	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
04/10/2018	13h30	GlobeNewswire Inc.	Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
03/10/2018	01h48	GlobeNewswire Inc.	Pain Therapeutics Announces Investor Call to Provide Strategic Update	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
30/08/2018	18h16	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
17/08/2018	23h15	GlobeNewswire Inc.	Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
17/08/2018	18h46	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
16/08/2018	13h00	GlobeNewswire Inc.	Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
16/08/2018	12h03	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)
15/08/2018	14h00	GlobeNewswire Inc.	Pain Therapeutics Awarded $3.2 Million NIH Grant to Study Alzheimer’s Disease	NASDAQ:PTIE	Pain Therapeutics, Inc. (MM)